Dr. Gaughan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1240 Lee St
Charlottesville, VA 22908Phone+1 434-924-9333Fax+1 434-244-7526
Summary
- Dr. Elizabeth Gaughan is an oncologist in Charlottesville, VA and is affiliated UVA Health. She primarily practices as the Emily Couric Clinical Cancer Center. She received her medical degree from Georgetown University School of Medicine in 2006 and completed her residency and fellowship training at the Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. Dr. Gaughan joined the University of Virginia in 2012 and specializes in cutaneous oncology and cancer immunotherapy. Dr. Gaughan is the lead of the Multidisciplinary Melanoma Clinical Team, and the Melanoma Translational and Clinical Research teams for the University of Virginia Comprehensive Cancer Center. Dr. Gaughan is also on the steering committee of the UVA Multidisciplinary Brain Metastasis Program. She is actively involved in the education and training of the next generation of health care professionals, including clinical, support and research trainees.
Education & Training
- Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2009 - 2012
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2006 - 2009
- Georgetown University School of MedicineClass of 2006
Certifications & Licensure
- VA State Medical License 2012 - 2024
- MA State Medical License 2008 - 2012
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Virginia Living's Top Doctors Virginia Living Magazine, 2024
- Executive Leadership in Health Care Drexel University College of Medicine, 2023-2024
- Press Ganey Recognition for Outstanding Patient Experience, yearly UVA Health System Outpatient Clinics, 2019-2023
- Join now to see all
Publications & Presentations
PubMed
- 1496 citationsAdjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV MelanomaJeffrey S. Weber, Mario Mandalà, Michele Del Vecchio, Helen Gogas, Ana Arance
The New England Journal of Medicine. 2017-09-10 - 73 citationsGenotype-driven therapies for non-small cell lung cancer: focus on EGFR, KRAS and ALK gene abnormalitiesElizabeth M. Gaughan, Daniel B. Costa
Therapeutic Advances in Medical Oncology. 2011-01-24 - 107 citationsQuantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of anti-PD-1 Therapies in Metastatic MelanomaDouglas B. Johnson, Jennifer Bordeaux, Ju Young Kim, Christine Vaupel, David L. Rimm
Clinical Cancer Research. 2018-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: